C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.590
+0.550 (18.09%)
At close: Mar 9, 2026, 4:00 PM EDT
3.590
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:30 PM EDT
C4 Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -104.99 | -105.32 | -132.49 | -128.18 | -83.89 | |
| Depreciation & Amortization | 1.96 | 1.82 | 1.88 | 1.68 | 1.49 | |
| Other Amortization | - | - | 0.41 | 0.71 | 0.72 | |
| Asset Writedown & Restructuring Costs | 17.17 | 6.42 | 6.16 | - | - | |
| Loss (Gain) From Sale of Investments | -2.74 | -5.4 | -3.78 | 0.71 | 1.88 | |
| Stock-Based Compensation | 19.1 | 29.66 | 27.24 | 30.02 | 21.51 | |
| Other Operating Activities | 0.1 | 0.01 | 0.7 | 5.9 | 1.42 | |
| Change in Accounts Receivable | 0.7 | 8.7 | -10.33 | 4.24 | -1.23 | |
| Change in Accounts Payable | -0.47 | -0.12 | 0.27 | -3.33 | -1.18 | |
| Change in Unearned Revenue | -18.84 | 9.88 | 3.77 | -22.65 | -25.05 | |
| Change in Other Net Operating Assets | -10.68 | -10.81 | -0.66 | 4.96 | -2.63 | |
| Operating Cash Flow | -98.69 | -65.16 | -106.84 | -105.94 | -86.97 | |
| Capital Expenditures | -0.61 | -0.18 | -1.71 | -5.5 | -1.28 | |
| Investment in Securities | -7.99 | -51.09 | 160.06 | 63.92 | -188.06 | |
| Investing Cash Flow | -8.6 | -51.27 | 158.35 | 58.42 | -189.34 | |
| Long-Term Debt Repaid | - | - | -12.5 | - | - | |
| Net Debt Issued (Repaid) | - | - | -12.5 | - | - | |
| Issuance of Common Stock | 126.32 | 45.15 | 57.73 | 0.78 | 183.1 | |
| Repurchase of Common Stock | -0.19 | -0.19 | -0.11 | - | - | |
| Other Financing Activities | 0.27 | 0.38 | 0.37 | 0.37 | -11.7 | |
| Financing Cash Flow | 126.4 | 45.34 | 45.49 | 1.15 | 171.4 | |
| Net Cash Flow | 19.1 | -71.09 | 97 | -46.37 | -104.9 | |
| Free Cash Flow | -99.3 | -65.34 | -108.55 | -111.44 | -88.24 | |
| Free Cash Flow Margin | -276.24% | -183.61% | -522.96% | -358.36% | -192.73% | |
| Free Cash Flow Per Share | -1.20 | -0.94 | -2.19 | -2.28 | -1.92 | |
| Cash Interest Paid | - | - | 0.99 | 1.62 | 1.31 | |
| Cash Income Tax Paid | - | - | 1 | - | - | |
| Levered Free Cash Flow | -54.3 | -35.43 | -66.06 | -62.78 | -30.22 | |
| Unlevered Free Cash Flow | -54.3 | -35.43 | -65.6 | -62.11 | -29.59 | |
| Change in Working Capital | -29.28 | 7.65 | -6.94 | -16.78 | -30.09 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.